Colgate-Palmolive (India) Ltd
Colgate-Palmolive (India) Ltd
Consumer Goods F&OKey Fundamentals
MidcapPersonal CareConsumer GoodsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Colgate-Palmolive (India) Ltd insights
44 extracted metrics + investor summaries across FY07–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 79.4%
- Company has been maintaining a healthy dividend payout of 112%
Weaknesses
2- Stock is trading at 34.0 times its book value
- The company has delivered a poor sales growth of 4.51% over past five years.
Growth Rate
AI Analysis — Bull vs Bear
Colgate-Palmolive (India) is a nearly debt-free FMCG company with a market cap of ₹54,188 Cr, trading at a PE of 40.3x and 34.3x book value. The company delivers exceptional return on equity (83% last year) but has recorded muted sales growth of ~5% CAGR over the past five years and a -2% TTM profit decline.
- Exceptional ROE of 83% in the last year and 79% average over 3 years, indicating highly efficient capital deployment
- Company is virtually debt-free, providing significant financial flexibility and resilience during economic downturns
- Healthy dividend payout ratio of 112%, rewarding shareholders with a 2.39% dividend yield — attractive for income-oriented investors
- Dominant market share in oral care category in India with strong brand recall, providing pricing power and distribution moat
- 10-year compounded profit growth of 8% CAGR demonstrates consistent long-term earnings expansion
- 3-year compounded profit growth of 8% shows sustained earnings momentum even in a challenging FMCG environment
- Parent company Colgate-Palmolive Co provides global R&D support, product innovation pipeline, and operational expertise
- Company has actively reduced debt over time, strengthening the balance sheet further from an already conservative position
- Stock trades at 34.3x book value — among the most expensive valuations in the Indian FMCG space, leaving limited margin of safety
- Compounded sales growth of only 5% over both 3-year and 5-year periods reflects limited top-line expansion in a growing consumer market
- TTM profit growth is negative at -2%, signalling near-term margin or demand pressures
- PE ratio of 40.3x is elevated for a company growing revenue at just 4-5% annually, implying stretched earnings multiples
- Stock CAGR of -8% over the past 1 year and just 1% over 3 years indicates sustained underperformance versus broader market indices
- Narrow product portfolio concentrated primarily in oral care limits diversification and addressable market expansion
- 5-year stock CAGR of only 4% significantly lags the broader Indian equity market returns over the same period
- High dividend payout of 112% exceeds net profits, potentially constraining reinvestment capacity for future growth initiatives
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 sales up 12% YoY Jul 29
Net sales of ₹1,591 crore, up 12% YoY. Gross margin expanded 110 bps to 69.7% driven by premium toothpaste growth and cost savings.
- Q1FY27 net profit rises Jul 29
Net profit rose 7-11% to ₹343 crore (variation depending on one-off exclusions). Margin expansion signals pricing power and operational efficiency.
- 2025 ESG goals achieved early Jul 28
Achieved 100% recyclable toothpaste tubes and 43% carbon reduction. Unveiled 2030 SMILE Strategy targeting net-zero by 2040 and reaching 245 million more children.
- Investor Day on Aug 17 Aug 5
Colgate-Palmolive (India) to host annual Investor Day on August 17, 2026 at 5:00 PM IST in hybrid format.
- 85th AGM resolutions passed Jul 30
All three ordinary resolutions passed with requisite majority at AGM held July 29, 2026, including board appointments and financial statement adoption.
TL;DR: Colgate-Palmolive (India) delivered a strong Q1FY27 with 12% revenue growth and meaningful gross margin expansion to 69.7%, reflecting premium mix and cost discipline. No visible headwinds emerged in the recent news cycle. ESG milestones add to long-term brand equity. The trend is positive, with upcoming Investor Day on Aug 17 likely to provide forward guidance on growth strategy.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,324 | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 | 1,595 | 1,603 |
| Expenses | 906 | 989 | 927 | 958 | 988 | 1,122 | 1,007 | 964 | 981 | 1,054 | 1,044 | 1,086 | 1,120 |
| Operating Profit | 418 | 482 | 468 | 532 | 508 | 497 | 454 | 498 | 453 | 465 | 442 | 510 | 483 |
| OPM % | 32% | 33% | 34% | 36% | 34% | 31% | 31% | 34% | 32% | 31% | 30% | 32% | 30% |
| Other Income | -5 | 21 | 18 | 23 | 23 | 76 | 20 | 19 | 18 | 15 | 31 | 0 | 19 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 44 | 44 | 41 | 42 | 42 | 42 | 41 | 38 | 38 | 37 | 36 | 35 | 39 |
| PBT | 369 | 458 | 443 | 511 | 489 | 530 | 433 | 478 | 432 | 442 | 436 | 474 | 462 |
| Tax % | 26% | 26% | 26% | 26% | 26% | 26% | 25% | 26% | 26% | 26% | 26% | 25% | 26% |
| Net Profit | 274 | 340 | 330 | 380 | 364 | 395 | 323 | 355 | 321 | 328 | 324 | 353 | 343 |
| EPS in Rs | 10.06 | 12.5 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 | 13.05 | 11.79 | 12.04 | 11.91 | 12.99 | 12.61 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,040 | 6,035 | 6,204 |
| Expenses | 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 4,082 | 4,165 | 4,304 |
| Operating Profit | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 1,958 | 1,870 | 1,900 |
| OPM % | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 32% | 31% | 31% |
| Other Income | 32 | 7 | 41 | 26 | 68 | 49 | 30 | 26 | 42 | 57 | 139 | 64 | 66 |
| Interest | 0 | 0 | 0 | 0 | 2 | 10 | 7 | 6 | 5 | 5 | 4 | 4 | 4 |
| Depreciation | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 163 | 146 | 148 |
| PBT | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,930 | 1,784 | 1,814 |
| Tax % | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | 26% | 26% | — |
| Net Profit | 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,437 | 1,325 | 1,348 |
| EPS in Rs | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.5 | 48.67 | 52.83 | 48.73 | 49.55 |
| Div. Payout % | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% | 97% | 119% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,637 | 1,557 |
| Borrowings | 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 61 | 47 |
| Other Liabilities | 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,293 | 1,777 |
| Total Liabilities | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,408 |
| Fixed Assets | 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 776 | 718 |
| CWIP | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 38 | 27 |
| Investments | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,204 | 2,663 |
| Total Assets | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,408 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 638 | 689 | 688 | 694 | 983 | 930 | 784 | 1,626 | 1,176 | 1,199 | 1,394 | 1,806 |
| Investing | -272 | -237 | -342 | -207 | -96 | -19 | 71 | -108 | -8 | 79 | 56 | 374 |
| Financing | -385 | -391 | -341 | -380 | -815 | -891 | -956 | -1,091 | -1,087 | -1,195 | -1,671 | -1,422 |
| Net Cash Flow | -18 | 61 | 5 | 107 | 73 | 20 | -101 | 427 | 82 | 83 | -221 | 758 |
| Free Cash Flow | 339 | 417 | 367 | 485 | 879 | 869 | 727 | 1,576 | 1,107 | 1,123 | 1,323 | 1,730 |
| CFO/OP | 103 | 100 | 105 | 93 | 113 | 104 | 76 | 127 | 101 | 88 | 100 | 121 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 | 14 | 13 |
| Inventory Days | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 | 76 | 75 |
| Days Payable | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 | 185 | 275 |
| Cash Conversion Cycle | -59 | -55 | -63 | -79 | -68 | -63 | -91 | -75 | -76 | -113 | -95 | -188 |
| Working Capital Days | -40 | -43 | -39 | -33 | -36 | -23 | -84 | -25 | -32 | -46 | -37 | -59 |
| ROCE % | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% | 105% | 108% |
Documents
Frequently Asked Questions about Colgate-Palmolive (India) Ltd
What does Colgate-Palmolive (India) Ltd do?
Where is Colgate-Palmolive (India) Ltd (COLPAL) listed?
Which sector does Colgate-Palmolive (India) Ltd belong to?
What is the market capitalisation of Colgate-Palmolive (India) Ltd?
What is the PE ratio of Colgate-Palmolive (India) Ltd?
What is the 52-week high and low of Colgate-Palmolive (India) Ltd?
Does Colgate-Palmolive (India) Ltd pay dividends?
What is the Return on Equity (ROE) of Colgate-Palmolive (India) Ltd?
How can I research Colgate-Palmolive (India) Ltd on Tapetide?
Company Information
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.[1]